Status:

COMPLETED

Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber Pacemakers

Lead Sponsor:

Vanderbilt University

Collaborating Sponsors:

National Institutes of Health (NIH)

Wake Forest University Health Sciences

Conditions:

Prolonged QT Interval

Eligibility:

All Genders

21+ years

Brief Summary

The purpose of this study is to learn what effect rapid atrial pacing (in patients with dual chamber pacemakers) will have on the electrocardiogram including the QT Interval. The investigators are als...

Detailed Description

This study requires a total of two study days as well as two follow up visits. During study day one, baseline blood will be drawn, a baseline electrocardiogram will be performed, and continuous QT Int...

Eligibility Criteria

Inclusion

  • Must be at least 21 years old
  • Must have a dual chamber pacemaker implanted more than three months ago
  • Must be followed by the Vanderbilt University Medical Center's Arrhythmia Device Clinic
  • The indication for the pacemaker must not be related to coronary artery disease (CAD) or congestive heart failure (CHF)

Exclusion

  • Cannot be pacemaker dependent
  • History of ventricular arrhythmias and/or implantable defibrillators (ICDs)
  • History of paroxysmal, persistent, or permanent atrial fibrillation (AF)
  • Congenital long QT syndrome
  • History of coronary artery disease
  • History of, or currently receiving, treatment for congestive heart failure
  • Unable to tolerate dual-chamber pacing (DDD) at 90 bpm due to palpitations, chest pain, shortness of breath, lightheadedness, dizziness, or presyncope
  • Pregnant women
  • Any patient without specific documentation of an echocardiogram negative for CHF (systolic or diastolic dysfunction)within five years prior to study enrollment
  • Any patient without specific documentation of an objective diagnostic test to rule out CAD within five years prior to study enrollment

Key Trial Info

Start Date :

April 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2012

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00883610

Start Date

April 1 2009

End Date

June 1 2012

Last Update

December 11 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232-8802